Notice of Issuance of Final Determination Concerning Certain Surgical and Isolation Gowns, 26503-26504 [2017-11839]

Download as PDF Federal Register / Vol. 82, No. 108 / Wednesday, June 7, 2017 / Notices sradovich on DSK3GMQ082PROD with NOTICES attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for review, discussion, and evaluation of individual intramural programs and projects conducted by the NATIONAL LIBRARY OF MEDICINE, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, Lister Hill National Center for Biomedical Communications. Date: September 7–8, 2017. Open: September 7, 2017, 9:00 a.m. to 12:00 p.m. Agenda: Review of research and development programs and preparation of reports of the Lister Hill National Center for Biomedical Communications. Place: National Library of Medicine, Building 38, 2nd Floor, The Lindberg Room, 8600 Rockville Pike, Bethesda, MD 20892. Closed: September 7, 2017, 12:00 p.m. to 4:30 p.m. Agenda: To review and evaluate personal qualifications, performance, and competence of individual investigators. Place: National Library of Medicine, Building 38, 2nd Floor, The Lindberg Room, 8600 Rockville Pike, Bethesda, MD 20892. Closed: September 8, 2017, 9:00 a.m. to 10:00 a.m. Agenda: To review and evaluate personal qualifications, performance, and competence of individual investigators. Place: National Library of Medicine, Building 38, 2nd Floor, The Lindberg Room, 8600 Rockville Pike, Bethesda, MD 20892. Contact Person: Karen Steely, Program Assistant, Lister Hill National Center for Biomedical Communications, National Library of Medicine, Building 38A, Room 7S707, Bethesda, MD 20892, 301–827–4385, ksteely@mail.nih.gov. Open: September 8, 2017, 10:00 a.m. to 11:30 a.m. Agenda: Review of research and development programs and preparation of reports of the Lister Hill National Center for Biomedical Communications. Place: National Library of Medicine, Building 38, 2nd Floor, The Lindberg Room, 8600 Rockville Pike, Bethesda, MD 20892. Contact Person: Karen Steely, Program Assistant, Lister Hill National Center for Biomedical Communications, National Library of Medicine, Building 38A, Room 7S707, Bethesda, MD 20892, 301–827–4385, ksteely@mail.nih.gov. Any interested person may file written comments with the committee by forwarding VerDate Sep<11>2014 16:37 Jun 06, 2017 Jkt 241001 the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS). Dated: June 1, 2017. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–11721 Filed 6–6–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Notice of Issuance of Final Determination Concerning Certain Surgical and Isolation Gowns U.S. Customs and Border Protection, Department of Homeland Security. ACTION: Notice of final determination. AGENCY: This document provides notice that U.S. Customs and Border Protection (‘‘CBP’’) has issued a final determination concerning the country of origin of certain surgical and isolation gowns. Based upon the facts presented, CBP has concluded in the final determination that the Dominican Republic is the country of origin of the surgical and isolation gowns for purposes of U.S. Government procurement. SUMMARY: The final determination was issued on May 31, 2017. A copy of the final determination is attached. Any party-at-interest, as defined in 19 CFR 177.22(d), may seek judicial review of this final determination within July 7, 2017. DATES: FOR FURTHER INFORMATION CONTACT: Cynthia Reese, Valuation and Special Programs Branch, Regulations and Rulings, Office of Trade (202–325– 0046). Notice is hereby given that on May 31, 2017, pursuant to Subpart B of part 177, Customs and Border Protection (CBP) SUPPLEMENTARY INFORMATION: PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 26503 Regulations (19 CFR part 177, subpart B), CBP issued a final determination concerning the country of origin of certain surgical and isolation gowns which may be offered to the United States Government under an undesignated government procurement contract. This final determination, in HQ H284665, was issued at the request of Global Resources International, Inc., under procedures set forth at 19 CFR part 177, subpart B, which implements Title III of the Trade Agreements Act of 1979, as amended (19 U.S.C. 2511–18). In the final determination, CBP has concluded that, based upon the facts presented, certain surgical and isolation gowns which are produced in the Dominican Republic from foreign nonwoven fabric by cutting the fabric into components and assembly of those components in the Dominican Republic are products of the Dominican Republic for purposes of U.S. Government procurement. Section 177.29, CBP Regulations (19 CFR 177.29), provides that notice of final determinations shall be published in the Federal Register within 60 days of the date the final determination is issued. Section 177.30, CBP Regulations (19 CFR 177.30), provides that any party-at-interest, as defined in 19 CFR 177.22(d), may seek judicial review of a final determination within 30 days of publication of such determination in the Federal Register. Dated: May 31, 2017. Alice A. Kipel, Executive Director, Regulations and Rulings, Office of Trade. Attachment HQ H284665 May 31, 2017 OT:RR:CTF:VS H284665 CMR CATEGORY: Origin Ms. Christi Roos, LCB M–PACT Solutions P.O. Box 30209 Memphis, TN 38118 RE: Government Procurement; Final Determination; Surgical and Isolation Gowns Dear Ms. Roos: This ruling is in response to your request of March 20, 2017, on behalf of your client, Global Resources International, Inc., for a country of origin determination for certain surgical and isolation gowns for purposes of government procurement under Title III of the Trade Agreements Act of 1979 (TAA), as amended (19 U.S.C. 2511 et seq.). Customs and Border Protection (CBP) issues country of origin advisory rulings and final determinations as to whether an article is or would be a product of a designated country or instrumentality for the purposes of granting waivers of certain ‘‘Buy American’’ E:\FR\FM\07JNN1.SGM 07JNN1 sradovich on DSK3GMQ082PROD with NOTICES 26504 Federal Register / Vol. 82, No. 108 / Wednesday, June 7, 2017 / Notices restrictions in U.S. law or for products offered for sale to the U.S. Government. This final determination concerns the country of origin of certain surgical and isolation gowns. As an importer of this merchandise, Global Resources International, Inc., is a party-atinterest within the meaning of 19 CFR 177.23(a) and is entitled to request this final determination. FACTS: The surgical and isolation gowns at issue were the subject of New York Ruling Letter (NY) N283263, dated March 7, 2017, which determined that these gowns are classified in subheading 6210.10.50, Harmonized Tariff Schedule of the United States (HTSUS). Samples of each type of gown were submitted to CBP and are described in NY N283263 as follows: The submitted sample, isolation gown, is constructed from 96% spunbonded polypropylene nonwoven fabric and 4% cotton knit fabric. The gown has a full back opening, long sleeves and a tie at the waist in the front of the gown that extends around the waist to fasten at the back. The garment will be used in the medical industry. The submitted sample, surgical gown, is constructed from 100% spunbonded polypropylene nonwoven fabric. The surgical gown has a hook and loop closure at the neck, long sleeves with knit cuffs and a full back opening. There is also a tie at the waist in the front of the gown that extends around the waist to fasten at the back. The garment will be used in the medical industry. Based on information from your initial ruling request, dated December 2, 2016, your supplemental submission, dated January 30, 2017, NY N283263, and responses via email to our questions, the manufacturing process is as follows: • Rolled nonwoven fabric from China, Vietnam, or India is shipped to the Dominican Republic. • All other components including thread and cotton fabric for the cuffs will be manufactured in the Dominican Republic. In the Dominican Republic: • The nonwoven fabric is laid on a cutting table and cut to specification using a cutting template. • Components are cut from the fabric— body, left arm, right arm, ties. • Arms are ultra-sonically welded to the body fabric or sewn. • In the case of the isolation gowns, the knit cuffs are sewn to the arms. • The gowns are folded, packaged and shipped to the United States. ISSUE: What is the country of origin of the surgical and isolation gowns described herein for purposes of U.S. Government procurement? LAW AND ANALYSIS: Pursuant to Subpart B of Part 177, 19 CFR 177.21 et seq., which implements Title III, Trade Agreements Act of 1979, as amended (19 U.S.C. 2511–2518), CBP issues country of origin advisory rulings and final determinations as to whether an article is or would be a product of a designated country or instrumentality for the purpose of granting waivers of certain ‘‘Buy American’’ VerDate Sep<11>2014 16:37 Jun 06, 2017 Jkt 241001 restrictions in U.S. law or practice for products offered for sale to the U.S. Government. The rule of origin set forth in 19 U.S.C. 2518(4)(B) states: An article is a product of a country or instrumentality only if (i) it is wholly the growth, product, or manufacture of that country or instrumentality, or (ii) in the case of an article which consists in whole or in part of materials from another country or instrumentality, it has been substantially transformed into a new and different article of commerce with a name, character, or use distinct from that of the article or articles from which it was so transformed. See also 19 CFR 177.22(a) defining ‘‘country of origin’’ in identical terms. In rendering advisory rulings and final determinations for purposes of U.S. Government procurement, CBP applies the provisions of Subpart B of Part 177 consistent with the Federal Procurement Regulations. See 19 CFR 177.21. In this regard, CBP recognizes that the Federal Procurement Regulations restrict the U.S. Government’s purchase of products to U.S.-made or designated country end products for acquisitions subject to the TAA. See 48 CFR 25.403(c)(1). With regard to the articles at issue, your request involves determining whether the articles are products of the Dominican Republic. The Federal Acquisition Regulations define ‘‘designated country’’ as including a Free Trade Agreement (FTA) country, and includes the Dominican Republic in the list of FTA countries. Further, the regulations define ‘‘Free Trade Agreement country end product’’ to mean, in relevant part, an article that: (1) Is wholly the growth, product, or manufacture of a Free Trade Agreement (FTA) country; or (2) In the case of an article that consists in whole or in part of materials from another country, has been substantially transformed in an FTA country into a new and different article of commerce with a name, character, or use distinct from that of the article or articles from which it was transformed. . . . See 48 CFR 25.003. As the articles at issue are not wholly the growth, product, or manufacture of the Dominican Republic, the substantial transformation standard as set forth in 19 U.S.C. 2518(4)(B) applies. As the articles at issue are textile products, the rules of origin for textile products for purposes of the customs laws and the administration of quantitative restrictions apply. In NY N283263, it was determined that the surgical and isolation gowns are classified in subheading 6210.10.50, HTSUS, and are not wholly obtained or produced in the Dominican Republic, their origin cannot be determined by application of 19 CFR 102.21(c)(1), i.e., wholly obtained or produced rule, and resort must be made to 19 CFR 102.21(c)(2), which provides that the origin of a good is the country ‘‘in which each foreign material incorporated in that good underwent an applicable change in tariff classification, and/or met any other requirement, specified for the good in PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 paragraph (e) of [102.21].’’ Section 102.21(e) provides, in pertinent part, for goods classifiable in heading 6210: (1) If the good consists of two or more component parts, a change to an assembled good of heading 6210 through 6212 from unassembled components, provided that the change is the result of the good being wholly assembled in a single country, territory, or insular possession. * * * * * The nonwoven fabric is cut in the Dominican Republic into component parts, i.e., the body, left arm, right arm and ties. These components are wholly assembled in the Dominican Republic into finished gowns. In the case of the isolation gowns, another component, i.e., the rib knit cuffs, are included in the assembly process. As the gowns are wholly assembled in the Dominican Republic, pursuant to 19 CFR 102.21(c)(2), the country of origin of the gowns is the Dominican Republic for U.S. Government procurement purposes. HOLDING: Based on the facts and analysis set forth above, for U.S. Government procurement purposes, the country of origin of the surgical and isolation gowns at issue is the Dominican Republic. Notice of this final determination will be given in the Federal Register, as required by 19 CFR 177.29. Any party-at-interest other than the party which requested this final determination may request, pursuant to 19 CFR 177.31, that CBP reexamine the matter anew and issue a new final determination. Pursuant to 19 CFR 177.30, any party-atinterest may, within 30 days after publication of the Federal Register notice referenced above, seek judicial review of this final determination before the Court of International Trade. Sincerely, Alice A. Kipel, Executive Director Regulations and Rulings Office of Trade [FR Doc. 2017–11839 Filed 6–6–17; 8:45 am] BILLING CODE P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [Docket No. USCBP–2017–0016] Request for Applicants for Appointment to the Commercial Customs Operations Advisory Committee (COAC) U.S. Customs and Border Protection, Department of Homeland Security (DHS). ACTION: Committee management; request for applicants for appointment to the COAC. AGENCY: U.S. Customs and Border Protection (CBP) is requesting that individuals who are interested in SUMMARY: E:\FR\FM\07JNN1.SGM 07JNN1

Agencies

[Federal Register Volume 82, Number 108 (Wednesday, June 7, 2017)]
[Notices]
[Pages 26503-26504]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-11839]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

U.S. Customs and Border Protection


Notice of Issuance of Final Determination Concerning Certain 
Surgical and Isolation Gowns

AGENCY: U.S. Customs and Border Protection, Department of Homeland 
Security.

ACTION: Notice of final determination.

-----------------------------------------------------------------------

SUMMARY: This document provides notice that U.S. Customs and Border 
Protection (``CBP'') has issued a final determination concerning the 
country of origin of certain surgical and isolation gowns. Based upon 
the facts presented, CBP has concluded in the final determination that 
the Dominican Republic is the country of origin of the surgical and 
isolation gowns for purposes of U.S. Government procurement.

DATES: The final determination was issued on May 31, 2017. A copy of 
the final determination is attached. Any party-at-interest, as defined 
in 19 CFR 177.22(d), may seek judicial review of this final 
determination within July 7, 2017.

FOR FURTHER INFORMATION CONTACT: Cynthia Reese, Valuation and Special 
Programs Branch, Regulations and Rulings, Office of Trade (202-325-
0046).

SUPPLEMENTARY INFORMATION: Notice is hereby given that on May 31, 2017, 
pursuant to Subpart B of part 177, Customs and Border Protection (CBP) 
Regulations (19 CFR part 177, subpart B), CBP issued a final 
determination concerning the country of origin of certain surgical and 
isolation gowns which may be offered to the United States Government 
under an undesignated government procurement contract. This final 
determination, in HQ H284665, was issued at the request of Global 
Resources International, Inc., under procedures set forth at 19 CFR 
part 177, subpart B, which implements Title III of the Trade Agreements 
Act of 1979, as amended (19 U.S.C. 2511-18). In the final 
determination, CBP has concluded that, based upon the facts presented, 
certain surgical and isolation gowns which are produced in the 
Dominican Republic from foreign nonwoven fabric by cutting the fabric 
into components and assembly of those components in the Dominican 
Republic are products of the Dominican Republic for purposes of U.S. 
Government procurement.
    Section 177.29, CBP Regulations (19 CFR 177.29), provides that 
notice of final determinations shall be published in the Federal 
Register within 60 days of the date the final determination is issued. 
Section 177.30, CBP Regulations (19 CFR 177.30), provides that any 
party-at-interest, as defined in 19 CFR 177.22(d), may seek judicial 
review of a final determination within 30 days of publication of such 
determination in the Federal Register.

    Dated: May 31, 2017.
Alice A. Kipel,
Executive Director, Regulations and Rulings, Office of Trade.

Attachment

HQ H284665
May 31, 2017

OT:RR:CTF:VS H284665 CMR

CATEGORY: Origin

Ms. Christi Roos, LCB
M-PACT Solutions
P.O. Box 30209
Memphis, TN 38118

RE: Government Procurement; Final Determination; Surgical and 
Isolation Gowns

    Dear Ms. Roos:
    This ruling is in response to your request of March 20, 2017, on 
behalf of your client, Global Resources International, Inc., for a 
country of origin determination for certain surgical and isolation 
gowns for purposes of government procurement under Title III of the 
Trade Agreements Act of 1979 (TAA), as amended (19 U.S.C. 2511 et 
seq.). Customs and Border Protection (CBP) issues country of origin 
advisory rulings and final determinations as to whether an article 
is or would be a product of a designated country or instrumentality 
for the purposes of granting waivers of certain ``Buy American''

[[Page 26504]]

restrictions in U.S. law or for products offered for sale to the 
U.S. Government. This final determination concerns the country of 
origin of certain surgical and isolation gowns. As an importer of 
this merchandise, Global Resources International, Inc., is a party-
at-interest within the meaning of 19 CFR 177.23(a) and is entitled 
to request this final determination.

FACTS:

    The surgical and isolation gowns at issue were the subject of 
New York Ruling Letter (NY) N283263, dated March 7, 2017, which 
determined that these gowns are classified in subheading 6210.10.50, 
Harmonized Tariff Schedule of the United States (HTSUS). Samples of 
each type of gown were submitted to CBP and are described in NY 
N283263 as follows:
    The submitted sample, isolation gown, is constructed from 96% 
spunbonded polypropylene nonwoven fabric and 4% cotton knit fabric. 
The gown has a full back opening, long sleeves and a tie at the 
waist in the front of the gown that extends around the waist to 
fasten at the back. The garment will be used in the medical 
industry.
    The submitted sample, surgical gown, is constructed from 100% 
spunbonded polypropylene nonwoven fabric. The surgical gown has a 
hook and loop closure at the neck, long sleeves with knit cuffs and 
a full back opening. There is also a tie at the waist in the front 
of the gown that extends around the waist to fasten at the back. The 
garment will be used in the medical industry.
    Based on information from your initial ruling request, dated 
December 2, 2016, your supplemental submission, dated January 30, 
2017, NY N283263, and responses via email to our questions, the 
manufacturing process is as follows:
     Rolled nonwoven fabric from China, Vietnam, or India is 
shipped to the Dominican Republic.
     All other components including thread and cotton fabric 
for the cuffs will be manufactured in the Dominican Republic.
    In the Dominican Republic:
     The nonwoven fabric is laid on a cutting table and cut 
to specification using a cutting template.
     Components are cut from the fabric--body, left arm, 
right arm, ties.
     Arms are ultra-sonically welded to the body fabric or 
sewn.
     In the case of the isolation gowns, the knit cuffs are 
sewn to the arms.
     The gowns are folded, packaged and shipped to the 
United States.

ISSUE:

    What is the country of origin of the surgical and isolation 
gowns described herein for purposes of U.S. Government procurement?

LAW AND ANALYSIS:

    Pursuant to Subpart B of Part 177, 19 CFR 177.21 et seq., which 
implements Title III, Trade Agreements Act of 1979, as amended (19 
U.S.C. 2511-2518), CBP issues country of origin advisory rulings and 
final determinations as to whether an article is or would be a 
product of a designated country or instrumentality for the purpose 
of granting waivers of certain ``Buy American'' restrictions in U.S. 
law or practice for products offered for sale to the U.S. 
Government.
    The rule of origin set forth in 19 U.S.C. 2518(4)(B) states:
    An article is a product of a country or instrumentality only if 
(i) it is wholly the growth, product, or manufacture of that country 
or instrumentality, or (ii) in the case of an article which consists 
in whole or in part of materials from another country or 
instrumentality, it has been substantially transformed into a new 
and different article of commerce with a name, character, or use 
distinct from that of the article or articles from which it was so 
transformed.

See also 19 CFR 177.22(a) defining ``country of origin'' in 
identical terms.

    In rendering advisory rulings and final determinations for 
purposes of U.S. Government procurement, CBP applies the provisions 
of Subpart B of Part 177 consistent with the Federal Procurement 
Regulations. See 19 CFR 177.21. In this regard, CBP recognizes that 
the Federal Procurement Regulations restrict the U.S. Government's 
purchase of products to U.S.-made or designated country end products 
for acquisitions subject to the TAA. See 48 CFR 25.403(c)(1).
    With regard to the articles at issue, your request involves 
determining whether the articles are products of the Dominican 
Republic. The Federal Acquisition Regulations define ``designated 
country'' as including a Free Trade Agreement (FTA) country, and 
includes the Dominican Republic in the list of FTA countries. 
Further, the regulations define ``Free Trade Agreement country end 
product'' to mean, in relevant part, an article that:
    (1) Is wholly the growth, product, or manufacture of a Free 
Trade Agreement (FTA) country; or
    (2) In the case of an article that consists in whole or in part 
of materials from another country, has been substantially 
transformed in an FTA country into a new and different article of 
commerce with a name, character, or use distinct from that of the 
article or articles from which it was transformed. . . .

See 48 CFR 25.003.

    As the articles at issue are not wholly the growth, product, or 
manufacture of the Dominican Republic, the substantial 
transformation standard as set forth in 19 U.S.C. 2518(4)(B) 
applies. As the articles at issue are textile products, the rules of 
origin for textile products for purposes of the customs laws and the 
administration of quantitative restrictions apply.
    In NY N283263, it was determined that the surgical and isolation 
gowns are classified in subheading 6210.10.50, HTSUS, and are not 
wholly obtained or produced in the Dominican Republic, their origin 
cannot be determined by application of 19 CFR 102.21(c)(1), i.e., 
wholly obtained or produced rule, and resort must be made to 19 CFR 
102.21(c)(2), which provides that the origin of a good is the 
country ``in which each foreign material incorporated in that good 
underwent an applicable change in tariff classification, and/or met 
any other requirement, specified for the good in paragraph (e) of 
[102.21].'' Section 102.21(e) provides, in pertinent part, for goods 
classifiable in heading 6210:
    (1) If the good consists of two or more component parts, a 
change to an assembled good of heading 6210 through 6212 from 
unassembled components, provided that the change is the result of 
the good being wholly assembled in a single country, territory, or 
insular possession.
* * * * *
    The nonwoven fabric is cut in the Dominican Republic into 
component parts, i.e., the body, left arm, right arm and ties. These 
components are wholly assembled in the Dominican Republic into 
finished gowns. In the case of the isolation gowns, another 
component, i.e., the rib knit cuffs, are included in the assembly 
process. As the gowns are wholly assembled in the Dominican 
Republic, pursuant to 19 CFR 102.21(c)(2), the country of origin of 
the gowns is the Dominican Republic for U.S. Government procurement 
purposes.

HOLDING:

    Based on the facts and analysis set forth above, for U.S. 
Government procurement purposes, the country of origin of the 
surgical and isolation gowns at issue is the Dominican Republic.
    Notice of this final determination will be given in the Federal 
Register, as required by 19 CFR 177.29. Any party-at-interest other 
than the party which requested this final determination may request, 
pursuant to 19 CFR 177.31, that CBP reexamine the matter anew and 
issue a new final determination. Pursuant to 19 CFR 177.30, any 
party-at-interest may, within 30 days after publication of the 
Federal Register notice referenced above, seek judicial review of 
this final determination before the Court of International Trade.

Sincerely,

Alice A. Kipel, Executive Director
Regulations and Rulings
Office of Trade

[FR Doc. 2017-11839 Filed 6-6-17; 8:45 am]
 BILLING CODE P